Abstract:Objective To develop HER-2 targeting boron-containing liposomes as the potential drug delivery vehicle for boron neutron capture therapy, studies on optimization of the developing conditions and targeting specificity of the prepared liposomes were carried out. Methods The liposomes were prepared by freezing-thawing and extrusion, and the loading of boron was performed using a pH gradient. Several drug-to-lipid ratios were tested for suitable entrapment efficiency. The effects of conjugation time (1 h or 3 h) on the yield of Trastuzumab conjugated to the micellar lipids DSPE-PEG-NHS were tested. Using the micelle transfer method, incorporation of Trastuzumab-PEG-DSPE into liposomes was studied after different temperature and time. The stability of the conjugate was tested by incubation of the liposomes diluted in the culture medium for up to 2 weeks at 4℃ or 37℃.To analyze the effect of temperature during incorporation, Trastuzumab was incubated for 4 h at 4, 20, 37 and 60℃ , then its receptor binding capacity was tested. The targeting specificity was studied in cultured SK-BR-3 cells by increasing amounts of free Trastuzumab in the medium. Results Examined under cryo-transmission microscopy, the prepared liposomes were about 100 nm in diameter, and boron crystals could be seen in the middle. The entrapment efficiency for the tested drug-to-lipid ratios was over 95%. One hour at room temperature was considered sufficient for the conjugation of Trastuzumab to the micellar lipids DSPE-PEG-NHS. Four hours at 60℃ gave the best yield in the incorporation of Trastuzumab-PEG-DSPE into liposomes. After 2 weeks at 37℃ 95% of the Trastuzumab remained still in the liposome fraction. Binding of Trastuzumab to SK-BR-3 cells was not considerably changed after incubated for 4 h at 4, 20, 37 and 60℃. The liposomes showed specific binding to the HER-2 receptor in SK-BR-3 cells. Conclusions The liposomes we prepared appear to be round, well separated and uniform in size with high entrapment efficiency. The liposomes are stable and keep the capacity of binding specificity.;

Trastuzumab-Conjugated Boron-Containing Liposomes for Tumor-Cell Targeting; Development and Cellular Studies

Cellular Targeting and Subcellular Distribution of HER-2 Targeting Boron Liposomes

Studies on Preparation of HER-2 Targeting Boron Liposomes and the Influencing Factors

Thermal Sensitive Liposomes Improve Delivery of Boronated Agents for Boron Neutron Capture Therapy

Evaluation of a Tumor-Targeting Oligosaccharide Nanosystem in BNCT on an Orthotopic Hepatocellular Carcinoma Model.

HER-2-Targeted Boron Neutron Capture Therapy with Carborane-integrated Immunoliposomes Prepared via an Exchanging Reaction

A Novel Boron Lipid to Modify Liposomal Surfaces for Boron Neutron Capture Therapy

EGF-receptor Targeted Liposomes with Boronated Acridine: Growth Inhibition of Cultured Glioma Cells after Neutron Irradiation

Design, Synthesis, and Evaluation of Lipopeptide Conjugates of Mercaptoundecahydrododecaborate for Boron Neutron Capture Therapy

Boron encapsulated in a liposome can be used for combinational neutron capture therapy

Linkage of boronated polylysine to glycoside moieties of polyclonal antibody; boronated antibodies as potential delivery agents for neutron capture therapy

[Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy]

Boron delivery with liposomes for boron neutron capture therapy (BNCT): biodistribution studies in an experimental model of oral cancer demonstrating therapeutic potential

Targeted drug delivery for boron neutron capture therapy

Asialoglycoprotein receptor targeted micelles containing carborane clusters for effective boron neutron capture therapy of hepatocellular carcinoma

[Liposomal boron delivery system for neutron capture therapy]

Boron-Containing Mesoporous Silica Nanoparticles with Effective Delivery and Targeting of Liver Cancer Cells for Boron Neutron Capture Therapy

Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy

Trastuzumab-functionalized bionic pyrotinib liposomes for targeted therapy of HER2-positive breast cancer

HER-2-targeted boron neutron capture therapy using an antibody-conjugated boron nitride nanotube/β-1,3-glucan complex

Boron Neutron Capture Therapy Enhanced by Boronate Ester Polymer Micelles: Synthesis, Stability, and Tumor Inhibition Studies